is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Dear Colleagues – Welcome to Düsseldorf!
After many months of social distancing and virtual meetings we will have the opportunity to meet in person, share ideas, have an open and vigorous scientific dialogue, and meet friends and colleagues from around the world at the upcoming EUROGIN meeting, taking place in Dusseldorf on April 10-12, 2022. The ambitious goal of Eliminating Cervical Cancer Globally remains a major focus, as does expanding these efforts to all cancers caused by HPV among women and men. As a community we will need to recover from the losses in cervical cancer screening and treatment and HPV vaccination rates that we witnessed during the COVID-19 pandemic, and quickly develop and implement an aggressive plan to forge forward to achieve this goal. Research is needed more than ever to develop cost-effective methods to increase screening, optimize screening protocols, and develop simple treatment strategies that are practical for all communities to implement, regardless of economic status.
As co-presidents, we look forward to EUROGIN 2022 as the meeting where we propel all of our efforts and recharge our collective urge to see a world in the not-too-distant future where cervical and other HPV-related cancers no longer exist.
A. Giuliano (USA) & P. Hillemanns (Germany), Congress Presidents
After a challenging period due to the COVID-19 pandemic, the EUROGIN 2022 Organizing Committee is thrilled to welcome the HPV community to meet again in person in Düsseldorf on April 10-12, 2022.
Back to the face-to-face format, the event will offer the usual high level of scientific content brought to you by the most reputable world-class experts in the field, throughout 4 days, comprising a large array of scientific and clinical sessions, and specialized workshops.
Coordinator: J. Monsonego (France)
Coordinators: P. Klussmann (Germany), K. Lang Kuhs (USA), E. Rettig (USA)
The EUROGIN HPV and Head & Neck Cancer Forum highlights recent advances and areas of active research in the field of HPV-related head and neck cancers.
This year’s Forum features the emerging role of biomarkers in screening and management of HPV-related oropharyngeal cancer, updates epidemiological data, emphasizes survivorship and surveillance, highlights deintensification trials and other therapeutic innovations, and a dedicated session focusing on molecular & immunologic considerations.
“Even in a non-conventional format, EUROGN 2021 was an excellent event, well organized and full of important topics and discussions.
Congratulations for making this possible in a very difficult year!”
“I thought EUROGIN was a great success. I learnt so much.
Of course, I miss the human interaction but well done for putting together such a comprehensive program”
“Your persistence during the difficult times has been admirable!”
“Thank you very much for the successful online meeting”
“Congrats to you and the whole Eurogin team to organize such a fantastic virtual format of the congress.”
Magnus Von Knebel Doeberitz